AI Can Predict Prognosis After Lumbar Disc Herniation Surgery
By Elana Gotkine HealthDay Reporter
FRIDAY, Feb. 9, 2024 -- Machine learning models can inform patients and clinicians about prognosis after lumbar disc herniation surgery, according to a study published online Feb. 7 in JAMA Network Open.
Bjørnar Berg, Ph.D., from Oslo Metropolitan University in Norway, and colleagues developed and validated prediction models for disability and pain 12 months after lumbar disc herniation surgery in a prospective registry-based prognostic study. The analysis included 22,707 surgical cases (21,161 patients) in the Norwegian Registry for Spine Surgery.
The researchers found that the proportion of cases experiencing treatment nonsuccess were 33, 27, and 31 percent based on improvement in the Oswestry Disability Index (ODI), Numeric Rating Scale (NRS) back pain, and NRS leg pain, respectively. Across all five geographic regions, the selected machine learning models showed consistent discrimination and calibration in internal-external cross-validation. For the ODI model, the C-statistic ranged from 0.81 to 0.84. Across regions, calibration slopes (point estimates, 0.94 to 1.03) and calibration intercepts (point estimates, −0.05 to 0.11) were also consistent. The C-statistic ranged from 0.75 to 0.80 for NRS back pain and from 0.74 to 0.77 for NRS leg pain.
"The models were based on routinely available preoperative predictors, making them readily amenable to further external validation in other spine registries and potentially implementable in electronic medical records systems to inform about individual prognosis and aid in surgical decision-making," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Etiology of Spinal Cord Injury Affects QOL Outcomes After Bladder Surgery
WEDNESDAY, July 3, 2024 -- For patients undergoing urinary diversion for neurogenic bladder (NGB), the postoperative impact on urinary-related quality of life (UrQOL) is milder...
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
Few Patients With Positive Margins After Basal Cell Excision Have Recurrence
MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.